IPO

Mumbai-based firm to double production capacity, expand into South India, and scale product portfolio ahead of planned public…

The company which was incorporated in 2006, has two operational manufacturing facilities in India, Unit I (Bommassandra) and Unit…

IPO to include fresh issue and Offer For Sale, with funds allocated for debt repayment and expansion

Focused on regulated markets, Rubicon Research plans to use proceeds for debt repayment, strategic acquisitions, and corporate…

Price Band fixed at ₹ 646 to ₹ 679 per equity share of face value of ₹ 2 each

The company gears up for market debut with SEBI approval for Rs 800 Crore IPO

Investors can bid for a minimum of 33 equity shares and in multiples of 33 equity shares thereafter

The IPO with a face value of Rs 2 each is entirely an offer for sale (OFS) of up to Rs 900 crore by Promoter and Promoter Group…

While Mankind Pharma’s IPO re-validates the long-term potential of the India Pharma Inc narrative, it won’t take much for the…

Bid/offer closing date will be Thursday, April 27, 2023